SCHEMBL30723183

SCHEMBL30723183

COCCOCCOCCNNC(=O)OCc1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.62
LMNA P02545 1/20 0.62
L3MBTL1 Q9Y468 2/20 0.46
CA1 P00915 3/20 0.46
CA2 P00918 3/20 0.46
CA12 O43570 2/20 0.46
CA9 Q16790 2/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
HTT P42858 1/20 0.46
MAPT P10636 1/20 0.45
ALDH1A1 P00352 2/20 0.45
P2RX7 Q99572 1/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
KYNU Q16719 1/20 0.43
POLB P06746 1/20 0.43
ACHE P22303 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18594580 0.87 SMN1; SMN2 (0.83) SMN1; SMN2LMNAL3MBTL1NPC1RAB9A
SCHEMBL8389256 0.82 SMN1; SMN2 (0.74) SMN1; SMN2LMNAL3MBTL1NPC1RAB9A
SCHEMBL14288938 0.82 LMNA (0.69) SMN1; SMN2LMNAL3MBTL1CA1CA2
SCHEMBL3705526 0.80 SMN1; SMN2 (0.54) SMN1; SMN2LMNAL3MBTL1CA1CA2
SCHEMBL7345362 0.79 HDAC3 (0.57) SMN1; SMN2LMNAL3MBTL1CA1CA2
SCHEMBL30823376 0.79 SMN1; SMN2 (0.97) SMN1; SMN2LMNAL3MBTL1CA1CA2
SCHEMBL18244515 0.78 LMNA (0.52) SMN1; SMN2LMNAL3MBTL1NPC1ALDH1A1
SCHEMBL26127818 0.78 LMNA (0.52) SMN1; SMN2LMNAL3MBTL1NPC1ALDH1A1
SCHEMBL26322851 0.78 LMNA (0.52) SMN1; SMN2LMNAL3MBTL1NPC1ALDH1A1
SCHEMBL18244630 0.78 LMNA (0.52) SMN1; SMN2LMNAL3MBTL1NPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117615753-A Lipid nanoparticle and method for preparing the same 泰纳治疗公司 2024-02-27 CN disclosed